CTOs on the Move

North Carolina Department of Environmental Quali

www.mrcnc.org

 
The NC Department of Environmental Quality (DEQ) is the lead stewardship agency for the protection of North Carolinas environmental resources. The organization, which has offices from the mountains to the coast, administers regulatory programs designed to protect air quality, water quality, and the publics health, and also works to advance an all-of-the-above energy strategy that fits North Carolinas needs. DEQ also offers technical assistance to businesses, farmers, local governments, and the public and encourages responsible behavior with respect to the environment through education programs provided at DEQ facilities and through the states school system. DEQ touches the lives of all North Carolinians ...
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million
  • www.mrcnc.org
  • 217 W Jones St
    Raleigh, NC USA
  • Phone: 877.623.6748

Executives

Name Title Contact Details
Sascha Meinrath
 Public Information Officer, State Energy Profile

Similar Companies

Hometown Landscape

Hometown Landscape is a Silver Spring, MD-based company in the Business Services sector.

cddb

cddb is a Carmel, IN-based company in the Business Services sector.

Visual Imprint

Visual Imprint is a San Diego, CA-based company in the Business Services sector.

Hunt Adkins

Hunt Adkins is a Minneapolis, MN-based company in the Business Services sector.

Vansen Pharma, Inc.

Vansen Pharma Inc. is a specialty pharmaceutical company focused on broad therapeutic areas that are anticipated to grow and present an opportunity for major expansion.  Vansen will expand its commercial presence by adding complimentary products through in-licensing, co-promotion and acquisitions, resulting in a comprehensive product portfolio.  With its US based sales force, Vansen can better serve the increasing healthcare needs of patients and enhance growth.  Vansen's current product portfolio of anti-infectives, including Factive®, Spectracef® and Cefditoren Pivoxil®, provides a strong and stable revenue base from which to grow and expand our company. Our experienced management team is aggressively pursuing acquisitions of accretive specialty products, including legacy drugs and cash flow positive healthcare companies.  We look forward to executing our growth strategy and creating lasting shareholder value for our investors.